These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
18 related articles for article (PubMed ID: 3887535)
1. [Prevention of motion sickness with a transdermal therapeutic system containing scopolamine. A randomized, comparative double-blind study in the German Federal Navy]. Becker G; Goossens H; Seemann K; Souchon F; Weitz T Dtsch Med Wochenschr; 1984 Dec; 109(49):1881-5. PubMed ID: 6499689 [TBL] [Abstract][Full Text] [Related]
2. [On the history of sea sickness]. Schadewaldt H Med Welt; 1967 Sep; 38():2258-65. PubMed ID: 4882368 [No Abstract] [Full Text] [Related]
6. [Transdermally applied scopolamine for continuous prevention of motion sickness. Revival of a 150-year-old method]. Becker G Schweiz Rundsch Med Prax; 1985 Mar; 74(11):271-6. PubMed ID: 3887535 [No Abstract] [Full Text] [Related]
7. Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications. Nachum Z; Shupak A; Gordon CR Clin Pharmacokinet; 2006; 45(6):543-66. PubMed ID: 16719539 [TBL] [Abstract][Full Text] [Related]
8. [Motion sickness at sea and in the air]. Kuitunen T; Leino T; Parkkola K Duodecim; 2011; 127(13):1378-80. PubMed ID: 21834343 [TBL] [Abstract][Full Text] [Related]